J Gynecol Oncol.
2024 Mar;35(2):e66. 10.3802/jgo.2024.35.e66.
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer
- Shim SH
1 - Lee JY2
- Lee YY3
- Park JY4
- Lee YJ2
- Kim SI5
- Han GH6
- Yang EJ7
- Noh JJ3
- Yim GW8
- Son JH9
- Kim NK10
- Kim TH11
- Kong TW9
- Choi YJ12
- Cho A13
- Lim H5
- Jang EB1
- Cho HW14
- Suh DH10
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea
- 2Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
- 3Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 4Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
- 5Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
- 6Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, Korea
- 7Department of Obstetrics and Gynecology, Research Institute of Medical Science, Soonchunhyang University Cheonan Hospital, Cheonan, Korea
- 8Department of Obstetrics and Gynecology, Dongguk University College of Medicine, Goyang, Korea
- 9Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea
- 10Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
- 11Department of Obstetrics and Gynecology, Konyang University Hospital, Daejeon, Korea
- 12Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 13Department of Obstetrics and Gynecology, Medical School of Jeju National University, Jeju National University Hospital, Jeju, Korea
- 14Department of Obstetrics and Gynecology, Guro Hospital, Korea University College of Medicine, Seoul, Korea
- KMID: 2564888
- DOI: http://doi.org/10.3802/jgo.2024.35.e66
Abstract
- In the 2023 series, we summarized the major clinical research advances in gynecologic oncology based on communications at the conference of Asian Society of Gynecologic Oncology Review Course. The review consisted of 1) Endometrial cancer: immune checkpoint inhibitor, antibody drug conjugates (ADCs), selective inhibitor of nuclear export, CDK4/6 inhibitors WEE1 inhibitor, poly (ADP-ribose) polymerase (PARP) inhibitors. 2) Cervical cancer: surgery in low-risk early-stage cervical cancer, therapy for locally advanced stage and advanced, metastatic, or recurrent setting; and 3) Ovarian cancer: immunotherapy, triplet therapies using immune checkpoint inhibitors along with antiangiogenic agents and PARP inhibitors, and ADCs. In 2023, the field of endometrial cancer treatment witnessed a landmark year, marked by several practice-changing outcomes with immune checkpoint inhibitors and the reliable efficacy of PARP inhibitors and ADCs.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Major clinical research advances in gynecologic cancer 2007
- Major clinical research advances in gynecologic cancer 2009
- Assessment and research of quality of life in gynecologic cancer patients
- Contemporary trends of endometrial cancer in Korean women
- Practical issues and research trends of oncofertility in gynecologic cancer
